Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX002290-01A2 |
| Title: | Novel small molecules targeting brain phospholipid dysregulation in AD |
| Principal Investigator: | Dongming Cai |
| Location: | Bronx, NY |
| Congressional District Code: | 13 |
| Research Service: | Rehabilitation R&D |
| Project Period: | December 2017 - November 2021 |
| FY 2021 Funding Amount: | $239,679 |
| Total Award Amount (all years): |
$1,004,200 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease of aging, with one in eight older Americans diagnosed with AD. It is also the most frequently diagnosed type of dementia within the Veterans Affairs (VA) Medical System, and one of the major causes of morbidity and mortality among veterans. The Department of VA estimates that 600,000 veterans suffered from severe AD and other forms of dementia in 2000, and this number is increased significantly today, because of the increas... |